Institutional investors purchased a net $211.5 thousand shares of ALIM during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 51.14% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTH RUN CAPITAL LP Bought 849.3 Thousand shares of Alimera Sciences Inc